The stock of India’s largest hospital chain Apollo Hospitals Enterprises gained over 12 per cent after the company reported better-than-expected December quarter results. In addition to recovery in its core operations, the company also outlined its strategy to strengthen its retail healthcare business and pharmacy verticals.
The hospital chain is targeting around Rs 10,000 crore revenue from its pharmacy business (from the current Rs 6,000 crore), while its diagnostics vertical is expected to clock around Rs 1,000 crore in the next three years, a four-fold increase from the current levels. Anubhav Aggarwal and Sayantan Maji of Credit Suisse say the